Skip to main content
Erschienen in: Cancer Causes & Control 10/2008

01.12.2008 | Original Paper

Anthropometric factors at age 20 years and risk of thyroid cancer

verfasst von: Takeshi Suzuki, Keitaro Matsuo, Yasuhisa Hasegawa, Akio Hiraki, Takakazu Kawase, Hideo Tanaka, Kazuo Tajima

Erschienen in: Cancer Causes & Control | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Effect of anthropometric factors at adolescence and the change since young age on thyroid cancer risk is unclear. Here, we conducted a case–control study to investigate the association between anthropometric factors at the time of diagnosis and age 20 years and risk of thyroid cancer. A total of 173 patients with thyroid cancer (papillary carcinoma, n = 167 and follicular carcinoma, n = 6) and 865 age- and sex-matched controls were included. Anthropometric factors were assessed using a validated self-administered questionnaire and categorized into three groups. Odd ratios (ORs) with 95% confidence intervals (CIs) were estimated using conditional logistic models adjusted for potential confounders. Results showed a positive association between current weights, weight at age 20 years and height, and thyroid cancer risk. Adjusted ORs in the top tertiles were 2.46 (95% CI, 1.54–3.94; trend p < 0.001) for current weight, 2.69 (95% CI, 1.71–4.25; trend p < 0.001) for weight at age 20 years and 2.44 (95% CI, 1.52–3.93; trend p < 0.001) for height compared with the lowest tertile. A positive association with current body surface area (BSA), BSA at age 20 years, and current body mass index was also observed, with respective adjusted ORs in the top tertile of 1.96 (95% CI, 1.23–3.11; trend p = 0.007), 1.82 (95% CI, 1.15–2.88; trend p = 0.007) and 1.71 (95% CI, 1.06–2.78; trend p = 0.034). In contrast, no association with risk was seen for a change in anthropometric factors since age 20 years. These findings suggested that body size in early life as well as in adult is associated with an increased risk of thyroid cancer.
Literatur
1.
Zurück zum Zitat Center for Cancer Control and Information Services, National Cancer Center (2006) Cancer incidence (1975–2001). Center for Cancer Control and Information Services, National Cancer Center, Japan Center for Cancer Control and Information Services, National Cancer Center (2006) Cancer incidence (1975–2001). Center for Cancer Control and Information Services, National Cancer Center, Japan
2.
Zurück zum Zitat Cardis E, Kesminiene A, Ivanov V et al (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724–732PubMedCrossRef Cardis E, Kesminiene A, Ivanov V et al (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724–732PubMedCrossRef
4.
Zurück zum Zitat Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M (1998) Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990–1994. Int J Obes Relat Metab Disord 22:684–687. doi:10.1038/sj.ijo.0800651 PubMedCrossRef Yoshiike N, Matsumura Y, Zaman MM, Yamaguchi M (1998) Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990–1994. Int J Obes Relat Metab Disord 22:684–687. doi:10.​1038/​sj.​ijo.​0800651 PubMedCrossRef
8.
Zurück zum Zitat Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P (2007) Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case–control study in New Caledonia. Am J Epidemiol 166(10):1140–1149 Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P (2007) Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case–control study in New Caledonia. Am J Epidemiol 166(10):1140–1149
9.
Zurück zum Zitat Tajima K, Hirose K, Inoue M, Takezaki T, Hamajima N, Kuroishi T (2000) A model of practical cancer prevention for out-patients visiting a hospital: the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev 1:35–47PubMed Tajima K, Hirose K, Inoue M, Takezaki T, Hamajima N, Kuroishi T (2000) A model of practical cancer prevention for out-patients visiting a hospital: the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev 1:35–47PubMed
10.
Zurück zum Zitat Hamajima N, Matsuo K, Saito T et al (2001) Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2:99–107PubMed Hamajima N, Matsuo K, Saito T et al (2001) Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2:99–107PubMed
11.
Zurück zum Zitat Inoue M, Tajima K, Hirose K et al (1995) Subsite-specific risk factors for colorectal cancer: a hospital-based case–control study in Japan. Cancer Causes Control 6:14–22. doi:10.1007/BF00051676 PubMedCrossRef Inoue M, Tajima K, Hirose K et al (1995) Subsite-specific risk factors for colorectal cancer: a hospital-based case–control study in Japan. Cancer Causes Control 6:14–22. doi:10.​1007/​BF00051676 PubMedCrossRef
12.
13.
Zurück zum Zitat Rothman KJ (2002) Epidemiology an introduction. Oxford University Press, New York, pp 82–84 Rothman KJ (2002) Epidemiology an introduction. Oxford University Press, New York, pp 82–84
14.
Zurück zum Zitat Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759–1762. doi:10.1002/1097-0142(19901015)66:8≤1759::AID-CNCR2820660820≥3.0.CO;2-XPubMedCrossRef Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y (1990) Sex hormone receptors in human thyroid tissues. Cancer 66:1759–1762. doi:10.1002/1097-0142(19901015)66:8≤1759::AID-CNCR2820660820≥3.0.CO;2-XPubMedCrossRef
15.
Zurück zum Zitat Takeichi N, Ito H, Haruta R, Matsuyama T, Dohi K, Tahara E (1991) Relation between estrogen receptor and malignancy of thyroid cancer. Jpn J Cancer Res 82:19–22PubMed Takeichi N, Ito H, Haruta R, Matsuyama T, Dohi K, Tahara E (1991) Relation between estrogen receptor and malignancy of thyroid cancer. Jpn J Cancer Res 82:19–22PubMed
16.
Zurück zum Zitat Knudsen N, Laurberg P, Rasmussen LB et al (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90:4019–4024. doi:10.1210/jc.2004-2225 PubMedCrossRef Knudsen N, Laurberg P, Rasmussen LB et al (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90:4019–4024. doi:10.​1210/​jc.​2004-2225 PubMedCrossRef
17.
Zurück zum Zitat Brabant G, Maenhaut C, Kohrle J et al (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7–R12. doi:10.1016/0303-7207(91)90018-N PubMedCrossRef Brabant G, Maenhaut C, Kohrle J et al (1991) Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 82:R7–R12. doi:10.​1016/​0303-7207(91)90018-N PubMedCrossRef
19.
Zurück zum Zitat Gasperi M, Martino E, Manetti L et al (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25:240–245PubMed Gasperi M, Martino E, Manetti L et al (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25:240–245PubMed
21.
Zurück zum Zitat Balkany C, Cushing GW (1995) An association between acromegaly and thyroid carcinoma. Thyroid 5:47–50PubMedCrossRef Balkany C, Cushing GW (1995) An association between acromegaly and thyroid carcinoma. Thyroid 5:47–50PubMedCrossRef
Metadaten
Titel
Anthropometric factors at age 20 years and risk of thyroid cancer
verfasst von
Takeshi Suzuki
Keitaro Matsuo
Yasuhisa Hasegawa
Akio Hiraki
Takakazu Kawase
Hideo Tanaka
Kazuo Tajima
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9194-x

Weitere Artikel der Ausgabe 10/2008

Cancer Causes & Control 10/2008 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.